• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 2.00% Nasdaq Up 1.66%

    More On DIVISLAB.NS

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Divi's Laboratories Limited (DIVISLAB.NS)

    -NSE
    987.15 Down 32.40(3.18%) Feb 12, 4:59AM EST
    Prev Close:1,019.55
    Open:1,021.20
    Bid:N/A
    Ask:987.15 x 400
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:960.25 - 1,026.10
    52wk Range:960.25 - 2,484.70
    Volume:736,094
    Avg Vol (3m):287,091
    Market Cap:262.06B
    P/E (ttm):30.78
    EPS (ttm):32.08
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in INR.

    Headlines

    • No Headlines available for DIVISLAB.NS at this time.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):8.72
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Divi's Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) and intermediates for generics in India. The company also offers building blocks for peptides and nucleotides; carotenoids, such as apocarotenal, beta... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback